Trial Profile
An Open-label Exploratory Study in Patient Volunteers With Ulcerative Colitis (UC), to Investigate Lamina Propria Presence and Evidence of Biological Effect of the Oral Domain Antibody V565
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Oct 2018
Price :
$35
*
At a glance
- Drugs V 565 (Primary)
- Indications Ulcerative colitis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors VHsquared
- 23 Oct 2018 New trial record